Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
about
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for interventionEarly decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts.Tumour budding in colorectal cancer: what do we know and what can we do?Understanding perspectives of signalling mechanisms regulating PEBP1 function.RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling.RKIP: A Key Regulator in Tumor Metastasis Initiation and Resistance to Apoptosis: Therapeutic Targeting and Impact
P2860
Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Loss of Raf-1 kinase inhibitor ...... c ductal adenocarcinoma (PDAC)
@en
Loss of Raf-1 kinase inhibitor protein
@nl
type
label
Loss of Raf-1 kinase inhibitor ...... c ductal adenocarcinoma (PDAC)
@en
Loss of Raf-1 kinase inhibitor protein
@nl
prefLabel
Loss of Raf-1 kinase inhibitor ...... c ductal adenocarcinoma (PDAC)
@en
Loss of Raf-1 kinase inhibitor protein
@nl
P2093
P2860
P356
P1476
Loss of Raf-1 kinase inhibitor ...... c ductal adenocarcinoma (PDAC)
@en
P2093
Agathi Kondi-Pafiti
Alessandro Lugli
Beat Gloor
Eva Karamitopoulou
P2860
P2888
P356
10.1186/1479-5876-11-311
P577
2013-12-14T00:00:00Z
P6179
1003100004